Pear Therapeutics’ three FDA authorised prescriptions available at OptumRx
OptumRx to make Pear’s three commercial Prescription Digital Therapeutics accessible to patients with Optum formulary access.
OptumRx to make Pear’s three commercial Prescription Digital Therapeutics accessible to patients with Optum formulary access.
Purchase price of US $ 1.5 billion upfront and up to USD 500 million in success-based milestone payments
The Prime Minister announced that 21st June onwards, the Government of India will provide free vaccines to all Indian citizens above 18 years of age
Has signed a 12-year, off-site, virtual power purchase agreement (VPPA) with Enel Green Power
Both ordinary resolutions sail through with over 99.6% votes in favour, strengthening leadership continuity at the drugmaker
The deal gives Vertex access to Halozyme’s Hypercon technology for up to three drug targets
For the biopharma industry, the study strengthens the case for balancing immune-cell engagement with tolerability in antibody discovery platforms
New digital health companion uses friendly, jargon-free communication to help users better understand reports
Landmark procedure restores 32-year-old CKD patient’s health, highlighting how public insurance is widening access to advanced renal care
CSR-led ‘Too Shy to Ask’ program expands across 1,000+ villages, with Panchayat-backed adolescent leadership driving behavioural change
Subscribe To Our Newsletter & Stay Updated